MINIMIZING RISK OF CHANGES Incoming batch-to-batch control of ingredients versus a fingerprint to monitor changes, and documented change control beyond CAS number reduce the risk of changes. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

This portfolio combines expertise in polymer formulation with controlled manufacturing conditions and robust change control management beyond the Chemical Abstracts Service (CAS) identification number. Pharmapack 2025, Europe’s leading packaging and drug delivery device event, will take place January 22–23 at the Paris Expo, Porte de Versailles.

As more consumers look to do their part and rethink their consumption habits, they are placing increased value on brands with responsible practices and products that align with such ideals. Although replacing virgin material with more eco-conscious options may present some challenges, a growing number of eco-conscious polymers offer on-par performance for many applications.

Great Place They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. 

Great Place They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

Great Place They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

Great Place They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

Duties and Responsibilities The Committee will: Assessment Process • Periodically review the results of formal assessments by management of the environmental liabilities for which the Company has known or probable environmental exposure and the adequacy of the Company’s financial reserves for environmental liabilities; • Semi-annually review the status of health and safety performance of the Company; • Semi-annually review the status of the Company’s product stewardship programs and performance; • Periodically review the Company’s staffing for its environmental, health and safety assessments and compliance; and 2 • Periodically review new environmental, physical security, health and safety laws and regulations applicable to the Company’s operations and issues or significant developments arising from pending regulatory and citizen group activities. Compliance Programs • At least annually review the programs and procedures established by the Company that monitor compliance with the Company’s policies, standards and practices, and laws and regulations with respect to safety, health, environmental, physical security and product stewardship, including providing oversight of the systems that are in place to monitor and mitigate the Company’s carbon footprint and physical risks associated with climate change; • Periodically review with management the significant safety, health, environmental, physical security, and product stewardship risks or exposures faced by the Company, if any, and steps taken by management to minimize such risks and exposures to the Company and its constituencies; • At least annually review the status of the Company’s environmental and safety audit process, assessing compliance with Company policies, standards, practices, laws and regulations; and • Periodically review claims, demands, administrative orders and legal proceedings against the Company regarding safety, health, environmental, physical security and product stewardship matters.

Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the dial-in numbers and a personal PIN, which are required to access the conference call.  Great Place

The Covid-19 pandemic is causing a need for greater numbers of N95 respirators and surgical masks than ever before, resulting in a global shortage that stands at unprecedented levels. PolyOne employs approximately 5,600 associates, is certified ACC Responsible Care® and Great Place to Work®, and is a founding member of the Alliance to End Plastic Waste.